Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price ...

The Centers for Medicare & Medicaid Services (CMS) released a list of prescription drugs it hopes to include in its new Medicare $2 Drug List Model, the agency announced Wednesday. Designed to limit ...